Legal Proceedings.
−Removed: On or about February 22, 2021, Pavlina Konstantinova, VectorY B.V., and Forbion International Management B.V.
+Added: On or about February 22, 2021, Dr.
+Added: Konstantinova, VectorY B.V., and Forbion International Management B.V.
commenced a summary proceeding in the Netherlands primarily seeking an order:
4 unchanged sentences
and (iii) precluding any monetary penalties pursuant to that non-competition agreement.
−Removed: The complaint also seeks payment of the costs of legal proceedings and a monetary monthly payment to Dr.
+Added: The complaint also sought payment of the costs of legal proceedings and a monetary monthly payment to Dr.
Konstantinova in lieu of a promise by uniQure biopharma B.V.
1 unchanged sentence
Konstantinova from her obligations under the non-competition agreement.
−Removed: The proceeding stems from a dispute between us, Dr.
−Removed: Konstantinova, VectorY and Forbion International Management B.V.
−Removed: over the hiring by VectorY of Dr.
−Removed: Konstantinova and several other former uniQure employees, which we believe is in violation of the employment agreements of those employees and involves the misappropriation of our proprietary resources.
−Removed: We believe that Forbion International Management B.V.
−Removed: is an affiliate of the Forbion group of companies that collectively own more than five percent of our outstanding ordinary shares.
−Removed: We are unable to express a view as to the likely outcome of this proceeding at this time.
+Added: On April 16, 2021, we settled all matters related to the dispute described above (the “Settlement”).
+Added: In connection with the Settlement, we received, among other things, preference shares in VectorY representing 5% of the fully diluted share capital in VectorY.
+Added: In addition, we and certain related Forbion entities entered into a Cooperation Agreement.
+Added: Under the terms of the Cooperation Agreement, we and the Forbion entities agreed to certain non-disparagement provisions, and the Forbion entities agreed, among other things, for a period of two years from April 16, 2021:
+Added: To vote all of their ordinary shares in uniQure N.V.
+Added: (1) in favor of the re-election of any persons serving on the Board of Directors of the Company (the “Board”) as of the date of the Cooperation Agreement and nominated by the Board for re-election;
+Added: (2) against any nominees to serve on the Board who have not been recommended by the Board, and (3) with respect to all other matters, other than certain defined exempt matters, in accordance with the Board’s recommendations as identified in our notice of general meeting or any supplement thereto.
+Added: Not to make any announcement or proposal with respect to, or offer, seek, propose, or indicate an interest in (A) any form of business combination or acquisition or other transaction relating to assets or securities of the uniQure N.V.
+Added: or any of its subsidiaries, (B) any form of restructuring, recapitalization, or similar transaction with respect to the uniQure N.V.
+Added: or any of its subsidiaries or (C) any form of tender or exchange offer for the ordinary shares of the uniQure N.V.
+Added: Not to make, engage in, assist with, or in any way participate in, directly or indirectly, any solicitation of proxies or written consents to vote (or withhold the vote of) any voting securities of uniQure N.V.
+Added: Not to take certain other specified actions aimed at changing or influencing the Board, management, or
+Added: control of the uniQure N.V.
Mine Safety Disclosures.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.